Fortunately, the FDA has approved antipsychotic treatments that help manage these destructive symptoms, and more are in ...

According to the U.S. Department of Veterans Affairs, veterans are more likely to develop Alzheimer's disease and other ...

The availability of amyloid-reducing therapies now makes detection of Alzheimer's disease in its early stages critical, ...

Cassava Sciences' RETHINK-ALZ trial is nearing data release. See why SAVA stock could see volatility depending on trial ...

Offering a simpler alternative to PET scans and CSF analysis, blood-based biomarker tests could improve accessibility of ...

New details have emerged about how Alzheimer’s disease affects the brain. Researchers led by the Allen Institute for Brain Science in Seattle and University of Washington Medicine have ...

The only approved treatments for Alzheimer’s disease are medications with limited effectiveness and a risk of severe, sometimes deadly, side effects. That’s why scientists search for therapies ...

Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% compared to similar medications, a new study found. But experts say more ...

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, ...